Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell Signaling in Plants01:25

Cell Signaling in Plants

5.7K
Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.7K
GPCR Desensitization01:12

GPCR Desensitization

6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

8.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.4K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.4K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

2.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

<sup>18</sup>F-fluciclovine positron emission tomography uptake is not exclusive to malignant brain tumors: Two cases of low-grade and benign lesions with detailed pathological findings.

Surgical neurology international·2026
Same author

Crystalglobulin-Induced Nephropathy and Cardiac Nonamyloidotic Immunoglobulin Deposition Disease: A Fatal Case Report.

Kidney medicine·2026
Same author

Technical principles of watertight dural closure in endoscopic endonasal surgery: How I do it.

Acta neurochirurgica·2026
Same author

Interactions between atomic-scale skyrmions in 2D chiral magnets.

Scientific reports·2026
Same author

Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case Report.

Kidney medicine·2026
Same author

Observation of the Einstein-de Haas effect in a Bose-Einstein condensate.

Science (New York, N.Y.)·2026

相关实验视频

Updated: Sep 9, 2025

A Caenorhabditis elegans Model System for Amylopathy Study
10:33

A Caenorhabditis elegans Model System for Amylopathy Study

Published on: May 17, 2013

10.6K

[Aβ受体PirB及其由LOTUS进行的调节]

Yuki Kawaguchi1, Kohtaro Takei1

  • 1Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine.

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
|August 31, 2025
PubMed
概括

研究人员确定了一种用于治疗阿尔茨海默病的新药标. 配对的免疫球蛋白类受体B (PirB) 和其调节器LOTUS显示出改善认知功能和对抗AD病理的潜力.

科学领域:

  • 神经科学
  • 药理学
  • 生物化学

背景情况:

  • 虽然阿尔茨海默病的发病因子已被广泛研究,但仍难以找到有效的治疗方法.
  • 配对免疫球蛋白样受体B (PirB) 是一个神经元受体,参与调节可塑性和对粉样β (Aβ) 的反应.

研究的目的:

  • 探索PirB作为一种新的阿尔茨海默病治疗点.
  • 研究侧嗅通道入门物质 (LOTUS) 作为PirB的内源抑制剂的作用及其在阿尔茨海默氏症治疗中的潜力.

主要方法:

  • 对PirB,LOTUS以及它们在神经元可塑性和Aβ病理中的作用进行现有研究.
  • 分析PirB作为Aβ受体的功能及其对神经元健康的影响.

主要成果:

  • 皮尔B作为神经元可塑性的负调节剂;其抑制增强了可塑性,脊柱密度和认知功能.
  • PirB作为Aβ的受体,调解神经毒性和降低可塑性.
  • 作为PirB的内源抗体,LOTUS抑制了Aβ诱导的神经毒性.

结论:

  • PirB是阿尔茨海默病的一个有前途的新药标.
  • 通过抑制PirB的Aβ受体功能,LOTUS可能对Aβ病理有治疗效果.

更多相关视频

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.9K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.2K

相关实验视频

Last Updated: Sep 9, 2025

A Caenorhabditis elegans Model System for Amylopathy Study
10:33

A Caenorhabditis elegans Model System for Amylopathy Study

Published on: May 17, 2013

10.6K
Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.9K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.2K